Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function
Lixin Wan(Beth Israel Deaconess Medical Center), Kexin Xu(The University of Texas at San Antonio Health Science Center), Yongkun Wei(The University of Texas MD Anderson Cancer Center), Jinfang Zhang(Beth Israel Deaconess Medical Center), Tao Han(Moffitt Cancer Center), Christopher J. Fry(Cell Signaling Technology (United States)), Zhao Zhang(The University of Texas at San Antonio Health Science Center), Yao Vickie Wang(The University of Texas at San Antonio Health Science Center), Liyu Huang(Beth Israel Deaconess Medical Center), Min Yuan(Beth Israel Deaconess Medical Center), Weiya Xia(The University of Texas MD Anderson Cancer Center), Wei-Chao Chang(China Medical University), Wen-Chien Huang(Mackay Memorial Hospital), Chien‐Liang Liu(Mackay Memorial Hospital), Yuan-Ching Chang(Mackay Memorial Hospital), Jinsong Liu(Beth Israel Deaconess Medical Center), Yun Wu(The University of Texas MD Anderson Cancer Center), Victor X. Jin(The University of Texas at San Antonio Health Science Center), Xiangpeng Dai(Beth Israel Deaconess Medical Center), Jianfeng Guo(Beth Israel Deaconess Medical Center), Jia Liu(Beth Israel Deaconess Medical Center), Shulong Jiang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jin Li(Moffitt Cancer Center), John M. Asara(Beth Israel Deaconess Medical Center), Myles Brown(Brigham and Women's Hospital), Mien‐Chie Hung(The University of Texas MD Anderson Cancer Center), Wenyi Wei(Beth Israel Deaconess Medical Center)
Cited by 196Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis